doi: 10.1136/heartasia-2017-010898.
eCollection 2017.
Challenges and opportunities in accessing trial data: an example from statin primary prevention trials
Affiliations
- PMID: 28469714
- PMCID: PMC5411734
- DOI: 10.1136/heartasia-2017-010898
Item in Clipboard
Challenges and opportunities in accessing trial data: an example from statin primary prevention trials
Heart Asia.
.
No abstract available
Conflict of interest statement
Competing interests: MDH receives grant support from the World Heart Federation to serve as its senior programme advisor for the Emerging Leaders programme, which is sponsored by Boehringer Ingelheim, Novartis, Bupa and AstraZeneca. MDH has received grant support from the Cochrane Collaboration, European Society of Cardiology and Center for Medicare and Medicaid Innovation for the production of other systematic reviews.
Similar articles
-
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1. Am J Cardiol. 2006. PMID: 16442935 Review.
-
Impact of the JUPITER trial on statin prescribing for primary prevention.Pharmacotherapy. 2014 Jan;34(1):9-18. doi: 10.1002/phar.1340. Epub 2013 Aug 12. Pharmacotherapy. 2014. PMID: 23940007 Clinical Trial.
-
Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.JAMA Cardiol. 2016 Sep 1;1(6):708-13. doi: 10.1001/jamacardio.2016.1577. JAMA Cardiol. 2016. PMID: 27439175
-
A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention.J Am Coll Cardiol. 2015 Mar 10;65(9):942-8. doi: 10.1016/j.jacc.2014.12.028. J Am Coll Cardiol. 2015. PMID: 25744012 Review.
-
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.Circulation. 2016 Apr 19;133(16):1574-81. doi: 10.1161/CIRCULATIONAHA.115.018383. Epub 2016 Mar 4. Circulation. 2016. PMID: 26945047
References
-
- Taylor F, Huffman MD, Macedo AF et al. . Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;(1):CD004816 doi:10.1002/14651858.CD004816.pub5 - DOI - PMC - PubMed
-
- Abramson JD, Rosenberg HG, Jewell N et al. . Should people at low risk of cardiovascular disease take a statin?. BMJ 2013;347:f6123–3. doi:10.1136/bmj.f612324149819 - DOI - PubMed
-
- Macedo AF, Taylor FC, Casas JP et al. . Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Medicine 2014;12:1–13. doi:10.1186/1741-7015-12-51 - DOI - PMC - PubMed
-
- Committee on Strategies for Responsible Sharing of Clinical Trial Data, Board on Health Sciences Policy, Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington, DC: National Academies Press (US), 2015. - PubMed
-
- Drazen JM. Sharing individual patient data from clinical trials. N Eng J Med 2015;372:201–2. doi:10.1056/NEJMp1415160 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources